Commentary: Emerging Technologies Oversight: Research, Regulation, and Commercialization

Journal of Law, Medicine and Ethics 37 (4):587-593 (2009)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1748-720x.2009.00432.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,897

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

Commentary: Emerging Technologies Oversight: Research, Regulation, and Commercialization.Robbin Johnson - 2009 - Journal of Law, Medicine and Ethics 37 (4):587-593.
What Does the History of Technology Regulation Teach Us about Nano Oversight?Gary E. Marchant, Douglas J. Sylvester & Kenneth W. Abbott - 2009 - Journal of Law, Medicine and Ethics 37 (4):724-731.
Emerging Technologies and Ethics: A Race-to-the-Bottom or the Top? [REVIEW]Raul Gouvea, Jonathan D. Linton, Manuel Montoya & Steven T. Walsh - 2012 - Journal of Business Ethics 109 (4):553-567.
Commentary: Who's Afraid of the RAC? Lessons from the Oversight of Controversial Science.Jeffrey P. Kahn - 2009 - Journal of Law, Medicine and Ethics 37 (4):685-687.
Commentary: Is It Possible to Determine the Extent to Which Informational Asymmetries and Prejudice Bias Responses?Terrance Hurley - 2009 - Journal of Law, Medicine and Ethics 37 (4):594-597.
Regulating nanotechnologies: Risk management models and nanomedicine. [REVIEW]Joachim Schummer & Elena Pariotti - 2008 - NanoEthics 2 (1):39-42.
Scientific self-regulation—so good, how can it fail?Patrick L. Taylor - 2009 - Science and Engineering Ethics 15 (3):395-406.
Governance of Nanotechnology and Nanomaterials: Principles, Regulation, and Renegotiating the Social Contract.George A. Kimbrell - 2009 - Journal of Law, Medicine and Ethics 37 (4):706-723.
Gene Therapy Oversight: Lessons for Nanobiotechnology.Susan M. Wolf, Rishi Gupta & Peter Kohlhepp - 2009 - Journal of Law, Medicine and Ethics 37 (4):659-684.
Evaluating Oversight Systems for Emerging Technologies: A Case Study of Genetically Engineered Organisms.Jennifer Kuzma, Pouya Najmaie & Joel Larson - 2009 - Journal of Law, Medicine and Ethics 37 (4):546-586.
Reproductive Entanglements: Body, State, and Culture in the Dys/Regulation of Child-Bearing.Rayna Rapp - 2011 - Social Research: An International Quarterly 78 (3):693-718.
Commentary: Evaluating Oversight of Human Drugs and Medical Devices.Susan Bartlett Foote - 2009 - Journal of Law, Medicine and Ethics 37 (4):629-632.
Motivating values and regulatory models for emerging technologies : stem cell research regulation in Argentina and the United Kingdom.Shawn H. E. Harmon - 2008 - In Michael D. A. Freeman (ed.), Law and Bioethics / Edited by Michael Freeman. Oxford University Press.
“Snake-oil,” “quack medicine,” and “industrially cultured organisms:” biovalue and the commercialization of human microbiome research. [REVIEW]Melody J. Slashinski, Sheryl A. McCurdy, Laura S. Achenbaum, Simon N. Whitney & Amy L. McGuire - 2012 - BMC Medical Ethics 13 (1):28-.
Post-Approval Monitoring and Oversight of U.S.-Initiated Human Subjects Research in Resource-Constrained Countries.Brandon Brown, Janni Kinsler, Morenike O. Folayan, Karen Allen & Carlos F. Cáceres - 2014 - Journal of Bioethical Inquiry 11 (2):119-123.

Analytics

Added to PP
2016-02-04

Downloads
11 (#1,137,899)

6 months
5 (#639,324)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

Add more references